Sie sind auf Seite 1von 3

Program & Batch: PGDM (2014-16), IMT Ghaziabad

Term: II
Course Name: Organizational Dynamics
Name of the faculty: S. Senthil Kumar
Topic/ Title : Stakeholder Analysis
Original
or Revised Write-up:
Original
Group Number: 6
Contact No. and email of Group
Coordinator:

Group Members: Sl. Roll No. Name
1 140101147 Sanket Padhy
2 140103157 Shweta Jadhav
3 140103064 Sashidhar G
4 140103165 Srikanth Guhan
5 140101032 Arpit Misra
6 140101117 Prerna Naresh
7 140102079 Mohit Sharma






Company Name: Forus Health Pvt Ltd
Date of analysis: 18
th
September

Describing the new venture that we would like to accomplish:

Forus's R&D is focusing on manufacturing a non-invasive (needle-free), wireless, continuous glucose
monitoring system designed to provide accurate, real-time blood glucose data conveniently and
continuously. It is being designed to provide reliable, continuous blood glucose data in order to improve
patient monitoring of blood glucose to allow for better overall clinical outcomes for patients in hospital
critical care units and, subsequently, for people with diabetes.






Stakeholder Interests/Expectations Importance
Patient
Elimination of finger pricks to check blood sugar or
glucose level (+)
High
Patient and Doctor
Continuous and effective monitoring of blood sugar
levels (+)
High
Doctor Easy decision making (+) Low
Hospitals
Threat of losing critical patient data because of
technical glitches (-)
Neutral
Pathologists Loss of business to pathologists (-) High
Manufacturers of
traditional CGMs
(invasive technique)
Loss of business due to older technology (-) High




STAKEHOLDER MAP

Low High
Positive
Easy decision making
Elimination of finger pricks to check blood
sugar or glucose level

Continuous and effective monitoring of
blood sugar levels
Negative
Loss of business due to older technology
Threat of losing critical patient data because
of technical glitches
Loss of business to pathologists


STAKEHOLDER ACTION PLANNING


Issues Actions Comments
Threat of losing critical
patient data because of
technical glitches
Maintain a copy of the data
for 7 days, locally
Technical glitches could consist of events
where the data got corrupted before
reaching the server/doctor
Loss of business for
manufacturers due to
older technology
We will release our
proprietary technology with
royalty charges
Older technologies should be rooted out
for betterment of humanity at large
Loss of business to
pathologists
Training programs will be
conducted to transfer
knowledge on the usage
process of needle free CGM
We are not capturing pathologists
markets. We are fighting invasive
technique market, i.e. for people using
needle based CGM

Das könnte Ihnen auch gefallen